A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients.

  • Bertram, Kelly (Primary Chief Investigator (PCI))
  • Burn, Katherine (Project Manager)

Project: Research

Project Details

StatusNot started
Effective start/end date1/11/2030/11/22

Keywords

  • Neurodegenerative diseases
  • Parkinson's disease
  • Clinical trial